[1]
|
Goldstein, J.L. and Brown, M.S. (1990) Regulation of the mevalonate pathway. Nature, 343, 425-430.
doi:10.1038/343425a0
|
[2]
|
Draeger, A., Monastyrskaya, K., Mohaupt, M., Hoppeler, H., Savolainen, H., Allemann, C. and Babiychuk, E.B. (2006) Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. Journal of Pathology, 210, 94-102. doi:10.1002/path.2018
|
[3]
|
Trapani, L., Melli, L., Segatto, M., Trezza, V., Campolongo, P., Jozwiak, A., Swiezewska, E., Pucillo, L.P., Moreno, S., Fanelli, F., Linari, M. and Pallottini, V. (2011) Effects of myosin heavy chain (MHC) plasticity induced by HMGCoA-reductase inhibition on skeletal muscle functions. FASEB Journal, 25, 4037-4047.
doi:10.1096/fj.11-184218
|
[4]
|
Lecomte, V., Meugnier, E., Euthine, V., Durand, C., Freyssenet, D., Nemoz, G., Rome, S., Vidal, H. and Lefai, E. (2009) A new role for sterol regulatory element binding protein 1 transcription factors in the regulation of muscle mass and muscle cell differentiation. Molecular and Cellular Biology, 30, 1182-1198.
doi:10.1128/MCB.00690-09
|
[5]
|
Heynekamp, J.J., Hunsaker, L.A., Vander Jagt, T.A., Royer, R.E., Deck, L.M. and Vander Jagt, D.L. (2008) Isocoumarin-based inhibitors of pancreatic cholesterol esterase. Bioorganic & Medicinal Chemistry, 16, 5285-5294. doi:10.1016/j.bmc.2008.03.016
|
[6]
|
Trapani, L. and Pallottini, V. (2010) Age-related hypercholesterolemia and HMG-CoA reductase dysregulation: Sex does matter (a gender perspective). Current Gerontology and Geriatrics Research, 2010, 420139.
doi:10.1155/2010/420139
|
[7]
|
Golomb, B.A. and Evans, M.A. (2008) Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism. American Journal of Cardiovascular Drugs, 8, 373-418.
doi:10.2165/0129784-200808060-00004
|
[8]
|
Pisarenko, O.I., Studneva, I.M., Lankin, V.Z., Konovalova, G.G., Tikhaze, A.K., Kaminnaya, V.I. and Belenkov, Y.N. (2001) Inhibitor of beta-hydroxy-beta-methylglutaryl coenzyme A reductase decreases energy supply to the myocardium in rats. Bulletin of Experimental Biology and Medicine, 132, 956-958.
doi:10.1023/A:1013611110134
|
[9]
|
Nawarskas, J.J. (2005) HMG-CoA reductase inhibitors and coenzyme Q10. Cardiology in Review, 13, 76-79.
|
[10]
|
Morkin, E. (2000) Control of cardiac myosin heavy chain gene expression. Microscopy Research and Technique, 50, 522-531.
doi:10.1002/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U
|
[11]
|
Hoh, J.F., McGrath, P.A. and Hale, P.T. (1978) Electrophoretic analysis of multiple forms of rat cardiac myosin: Effects of hypophysectomy and thyroxine replacement. Journal of Molecular and Cellular Cardiology, 10, 1053-1076. doi:10.1016/0022-2828(78)90401-7
|
[12]
|
Swynghedauw, B. (1986) Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiological Review, 66, 710-771.
|
[13]
|
Izumo, N., Fujita, T., Nakamuta, H. and Koida, M. (2001) Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfa1- and BMP-2-independent manner. Methods and Findings in Experimental and Clinical Pharmacology, 23, 389-394.
doi:10.1358/mf.2001.23.7.662123
|
[14]
|
Kakinuma, Y., Miyauchi, T., Suzuki, T., Yuki, K., Murakoshi, N., Goto, K. and Yamaguchi, I. (2002) Enhancement of glycolysis in cardiomyocytes elevates endothelin-1 expression through the transcriptional factor hypoxia-inducible factor-1 alpha. Clinical Science (London), 103, 210S-214S.
|
[15]
|
Krenz, M., Sadayappan, S., Osinska, H.E., Henry, J.A., Beck, S., Warshaw, D.M. and Robbins, J. (2007) Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart. Journal of Biological Chemistry, 282, 24057-24064.
doi:10.1074/jbc.M704574200
|
[16]
|
Trapani, L., Segatto, M., La Rosa, P., Fanelli, F., Moreno, S., Marino, M. and Pallottini, V. (2012) 3-hydroxy 3- methylglutaryl coenzyme a reductase inhibition impairs muscle regeneration. Journal of Cellular Biochemistry, 113, 2057-2063. doi:10.1002/jcb.24077
|